Maintenance ECT in Recurrent Depression and Treatment Resistant Schizophrenia

Maintenance ECT in Recurrent Depression and Treatment Resistant Schizophrenia

Objective:Electroconvulsive therapy (ECT) has been used for treatment of depression and psychosis for a long time. A less known way of use is as a maintenance treatment for keeping patients stable during remission. Recently ECT has been increasingly used for schizophrenia and depression after remiss...

Full description

Bibliographic Details
Main Author:	Sinem Zeynep METİN
Format:	Article
Language:	English
Published:	Galenos Publishing House 2022-06-01
Series:	Bezmiâlem Science
Subjects:	ect maintenance recurrent depressive disorder treatment resistant schizophrenia
Online Access:	http://bezmialemscience.org/archives/archive-detail/article-preview/maintenance-ect-in-recurrent-depression-and-treatm/52321

Similar Items

Vns as alternative treatment for maintenance ect in a patient with treatment resistant depression - a case study
by: C. Migchels, et al.
Published: (2021-04-01)

Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report
by: Ito M, et al.
Published: (2019-06-01)

Comparison effects of clozapine, ECT and combination ECTand clozapine on resistance treatment of schizophrenia(Double blind)
by: S.H. Hosseini, et al.
Published: (2006-01-01)

Electroconvulsive therapy in treatment resistant schizophrenia: Old beacon of hope when nothing else works
by: C. Adão, et al.
Published: (2022-06-01)

Repeated intravenous esketamine treatment in patients with ECT-resistant major depressive disorder
by: A. Safai Pour, et al.
Published: (2022-12-01)

Treatment-Resistant Depression – What is the Effective Maintenance Treatment
by: D. Kolar
Published: (2022-06-01)

Maintenance Electroconvulsive Therapy
by: Mustafa Melih Bilgi, et al.
Published: (2010-01-01)

Managing treatment resistance in schizophrenia: A joint study in Hong Kong and Singapore
by: Shushan Zheng, et al.
Published: (2022-10-01)

A review of ketamine’s role in ECT and non-ECT settings
by: Jankauskas V, et al.
Published: (2018-06-01)

Serum Mature BDNF Level Is Associated with Remission Following ECT in Treatment-Resistant Depression
by: Marion Psomiades, et al.
Published: (2022-01-01)

ECT in an Adolescent With Schizophrenia and Seizures: Case Report
by: Anna Gralewicz, et al.
Published: (2021-11-01)

Editorial: Treatment resistance in psychotic disorders
by: Santanu Nath, et al.
Published: (2023-03-01)

Underuse of recommended treatments among people living with treatment-resistant psychosis
by: Julia M. Lappin, et al.
Published: (2022-09-01)

Case report on Cotard’s syndrome (CS) in a patient with schizophrenia: a rare case from Malaysia
by: Natasha Subhas, et al.
Published: (2021-08-01)

Evolution of Electroconvulsive Therapy during the COVID-19 pandemic in the Regional ECT Unit of the Region of Murcia
by: M.A. Cutillas Fernández, et al.
Published: (2022-06-01)

Protocol to maintain ECT in COVID-19 pandemic
by: M. Martínez-Roig, et al.
Published: (2021-04-01)

Effect of Continuation-Maintenance Electroconvulsive Therapy on Hospitalization: A Retrospective Mirror-Image Study
by: Sombatcharoen-non N, et al.
Published: (2023-06-01)

Higher Depression Scores in Patients with Drug-Resistant Schizophrenia
by: Georgi Panov
Published: (2022-07-01)

Maintenance electro convulsive therapy for recurrent catatonia – a case report
by: Nair V Indu, et al.
Published: (2018-11-01)

Investigating the Role of Leukocyte Telomere Length in Treatment-Resistant Depression and in Response to Electroconvulsive Therapy
by: Claudia Pisanu, et al.
Published: (2021-10-01)

Comparison between neurostimulation techniques rapid transcranial magnetic stimulation vs electroconvulsive therapy for the treatment of resistant depression: patient preference and cost-effectiveness
by: Magnezi R, et al.
Published: (2016-08-01)

Commonalities and differences in ECT-induced gray matter volume change between depression and schizophrenia
by: Hirotsugu Kawashima, et al.
Published: (2023-01-01)

Ketamine as an alternative to ECT in catatonia in elderly women with bipolar disorder: A case report
by: Shanthi Sarma, et al.
Published: (2023-04-01)

Critical analysis of the electroconvulsive therapy unit of centro hospitalar lisboa norte
by: C. Perestrelo Da Silva, et al.
Published: (2021-04-01)

The Influence of Electroconvulsive Therapy (ECT) on Brain-Derived Neurotrophic Factor (BDNF) Plasma Level in Patients with Schizophrenia—A Systematic Review and Meta-Analysis
by: Anna Maria Szota, et al.
Published: (2023-09-01)

Electroconvulsive therapy (ECT) in the management of a bipolar disorder with comorbid OCD: a case report and review of the literature
by: A. Adouni, et al.
Published: (2022-06-01)

A two-site, open-label, non-randomized trial comparing Focal Electrically-Administered Seizure Therapy (FEAST) and right unilateral ultrabrief pulse electroconvulsive therapy (RUL-UBP ECT)
by: Gregory L. Sahlem, et al.
Published: (2020-09-01)

Clinical characteristics and potential association to Parkinson’s disease and dementia with Lewy bodies in patients with major depressive disorder who received maintenance electroconvulsive therapy: a retrospective chart review study
by: Shun Kudo, et al.
Published: (2023-04-01)

Decomposing Working Memory in Recurrent Major Depression: Impaired Encoding and Limited Maintenance Immune-to-Encoding Constraint
by: Zhitang Chen, et al.
Published: (2022-12-01)

Treatment resistant schizophrenia in Slovenian population
by: Tea Terzić, et al.
Published: (2014-10-01)

Identification of Effective Factors in Recurrence of Schizophrenia Spectrum Disorder Using Poisson Regression Model
by: Omran Davarinejad, et al.
Published: (2021-12-01)

m6A readers ECT2/ECT3/ECT4 enhance mRNA stability through direct recruitment of the poly(A) binding proteins in Arabidopsis
by: Peizhe Song, et al.
Published: (2023-04-01)

Electroconvulsive Therapy Practice in Thailand: A Nationwide Survey
by: Kittayarak K, et al.
Published: (2022-10-01)

ECT9 condensates with ECT1 and regulates plant immunity
by: Hui Wang, et al.
Published: (2023-04-01)

The YTHDF proteins ECT2 and ECT3 bind largely overlapping target sets and influence target mRNA abundance, not alternative polyadenylation
by: Laura Arribas-Hernández, et al.
Published: (2021-09-01)

Catatonia: Clinical Overview of the Diagnosis, Treatment, and Clinical Challenges
by: Amber N. Edinoff, et al.
Published: (2021-11-01)

Dissociative Model in Patients With Resistant Schizophrenia
by: Georgi Panov
Published: (2022-02-01)

Can the Addition of Maintenance Electroconvulsive Therapy to Pharmacotherapy Improve Relapse Prevention in Severe Major Depressive Disorder? A Randomized Controlled Trial
by: Erika Martínez-Amorós, et al.
Published: (2021-10-01)

Duration of Hospitalization According to the Type of Treatment in Patients Diagnosed With Schizophrenia: A Retrospective Cross-sectional Study
by: Ali Massoudifar, et al.
Published: (2023-07-01)

Clinical role of brexpiprazole in depression and schizophrenia
by: Parikh NB, et al.
Published: (2017-03-01)